Source: International Congress 2015 – More paediatric asthma and allergy
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aleksandra Szczepankiewicz (Poznan, Poland), Aleksandra Szczepankiewicz, Paulina Sobkowiak, Aleksandra Hoffmann, Beata Narozna, Anna Breborowicz. Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma. Eur Respir J 2015; 46: Suppl. 59, 4198

Member's Comments

No comment yet.

Related content which might interest you: Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 IL-25 receptor expression on basophil membrane is related to phenotype and severity of asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 YAP1 in the hippo pathway influences the risk of asthma Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 New outlook on the Th1/Th2-alternative signaling pathways in asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 The expression of the negative regulator of gene transcription SOCS3 as the crucial marker in the asthma pathogenesis Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 The muscarinic M3 receptor regulates allergen-induced airway remodeling in mice Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 MAPKAP kinase 2(MK2) expression is associated with severe asthma Source: International Congress 2016 – Mechanisms of disease Year: 2016 Impaired protein tyrosine phosphatase PTPRR reduces response to corticosteroid in mononuclear cells Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Notch signalling in human basophils Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 The effect of smoking on phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog deleted from chromosome 10 (PTEN) mRNA expression in human airway epithelial cells Source: International Congress 2014 – Mechanistic studies of the airway epithelium Year: 2014 The crucial role of the expression of negative regulator of gene transcription SOCS5 in asthma pathogenesis Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Deletion of peroxiredoxin 6 potentiates OVA-induced asthma epithelial-mesenchymal transition through EGFR pathway Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013